The established prognostic gene signature showed a five-gene prognostic signature, which had an effective prediction ability of the progression and prognosis of CM patients, comprising of NOP2, NSUN3, NSUN6, DNMT2, and YBX1 via Lasso Cox regression analysis. This evidence concerns the gene NOP2 and cutaneous mastocytosis.